ADARx Pharmaceuticals, Inc. (ADRX)
17.63
-0.05
(-0.28%)
USD |
NASDAQ |
Oct 23, 16:00
17.80
+0.17
(+0.96%)
After-Hours: 20:00
ADARx Pharmaceuticals Market Cap : 1.883B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.883B |
| October 22, 2026 | 1.888B |
| October 21, 2026 | 1.830B |
| October 20, 2026 | 1.888B |
| October 19, 2026 | 1.883B |
| October 16, 2026 | 1.885B |
| October 15, 2026 | 1.890B |
| October 14, 2026 | 1.904B |
| October 13, 2026 | 1.890B |
| October 12, 2026 | 1.919B |
| October 09, 2026 | 1.899B |
| Date | Value |
|---|---|
| October 08, 2026 | 1.888B |
| October 07, 2026 | 1.851B |
| October 06, 2026 | 1.984B |
| October 05, 2026 | 2.035B |
| October 02, 2026 | 1.949B |
| October 01, 2026 | 2.087B |
| September 30, 2026 | 2.130B |
| September 29, 2026 | 2.204B |
| September 28, 2026 | 2.146B |
| September 25, 2026 | 2.067B |
| September 24, 2026 | 1.816B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.189B |
| Oncolytics Biotech, Inc. | 62.61M |
| Sangamo Therapeutics, Inc. | 47.64M |
| Sarepta Therapeutics, Inc. | 1.873B |
| Anixa Biosciences, Inc. | 103.41M |
Market Cap Related Metrics
| PS Ratio | 608.57 |
| Price to Free Cash Flow | 7.564 |
| Price | 17.63 |
| Earnings Yield | -4.36% |